menu
    • menu
    [{"orgOrder":0,"company":"Alastin Skincare","sponsor":"Galderma","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Peptide, Unconjugated","year":"2022","type":"Acquisition","leadProduct":"Herbal Extract","moa":"||Undisclosed","graph1":"Dermatology","graph2":"Approved FDF","graph3":"Alastin Skincare","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Alastin Skincare \/ Galderma","highestDevelopmentStatusID":"15","companyTruncated":"Alastin Skincare \/ Galderma"},{"orgOrder":0,"company":"Alastin Skincare","sponsor":"Galderma","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Peptide, Unconjugated","year":"2021","type":"Acquisition","leadProduct":"Herbal Extract","moa":"||Undisclosed","graph1":"Dermatology","graph2":"Approved FDF","graph3":"Alastin Skincare","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Cream","sponsorNew":"Alastin Skincare \/ Galderma","highestDevelopmentStatusID":"15","companyTruncated":"Alastin Skincare \/ Galderma"}]

    Find Clinical Drug Pipeline Developments & Deals by Alastin Skincare

    Menu

    Alastin Skincare

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Alastin Skincare

                            U.S.A arrow
                            CPhI India
                            Not Confirmed

                            Alastin Skincare

                            U.S.A arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Palmitoyl Tripeptide-1,Herbal Extract,Myristoyl Tripeptide-1

                            Therapeutic Area : Dermatology

                            Study Phase : Approved FDF

                            Sponsor : Galderma

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Galderma Successfully Completes Acquisition of ALASTIN Skincare

                            Details : ALASTIN’s synergistic portfolio in skincare will increase Galderma’s ability to serve the needs by the patented TriHex Technology®, a blend of peptides (Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1) and active botanicals to support the appearance o...

                            Product Name : Alastin Skincare

                            Product Type : Peptide, Unconjugated

                            Upfront Cash : Undisclosed

                            January 05, 2022

                            Lead Product(s) : Palmitoyl Tripeptide-1,Herbal Extract,Myristoyl Tripeptide-1

                            Therapeutic Area : Dermatology

                            Highest Development Status : Approved FDF

                            Sponsor : Galderma

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Alastin Skincare

                            U.S.A arrow
                            CPhI India
                            Not Confirmed

                            Alastin Skincare

                            U.S.A arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Palmitoyl Tripeptide-1,Herbal Extract,Myristoyl Tripeptide-1

                            Therapeutic Area : Dermatology

                            Study Phase : Approved FDF

                            Sponsor : Galderma

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Galderma to Acquire Award-Winning ALASTIN Skincare® Enhancing its Integrated Dermatology Platform to Continue...

                            Details : ALASTIN’s product offerings are backed by the patented TriHex Technology®, a proprietary blend of peptides and active botanicals to support the appearance of rejuvenated skin, which will now be apart of Galderma.

                            Product Name : Alastin Skincare

                            Product Type : Peptide, Unconjugated

                            Upfront Cash : Undisclosed

                            November 29, 2021

                            Lead Product(s) : Palmitoyl Tripeptide-1,Herbal Extract,Myristoyl Tripeptide-1

                            Therapeutic Area : Dermatology

                            Highest Development Status : Approved FDF

                            Sponsor : Galderma

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth